HIGHLIGHTS
- who: Dual ART and colleagues from the Division of Infectious Diseases, ASST Papa Giovanni XXIII, Bergamo, Italy Division of Infectious Diseases, University of Modena, Modena, Italy have published the article: BMC Infectious Diseases outcome of lamivudine/ therapy in HIV-infected virologically suppressed patients, in the Journal: (JOURNAL)
- what: The authors report results in patients switched while virologically suppressed to the combination of_(DTG) plus (3TC). The main reasons for therapeutic switch were concomitant diseases and abnormality of laboratory tests followed by drug-related adverse events or possible adverse events or a potential drug-drug interaction . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.